Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 16 July 2009, Vol. 114, No. 3, pp. 723-732.
Prepublished online as a Blood First Edition Paper on April 15, 2009; DOI 10.1182/blood-2009-02-205930.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
blood-2009-02-205930v1
114/3/723    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Prokopi, M.
Right arrow Articles by Mayr, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prokopi, M.
Right arrow Articles by Mayr, M.
Related Collections
Right arrow Platelets and Thrombopoiesis
Right arrow Vascular Biology
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

VASCULAR BIOLOGY

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

Marianna Prokopi1, Giordano Pula1, Ursula Mayr1, Cécile Devue2, Joy Gallagher3, Qingzhong Xiao1, Chantal M. Boulanger2, Nigel Westwood4, Carmen Urbich5, Johann Willeit6, Marianne Steiner7, Johannes Breuss8, Qingbo Xu1, Stefan Kiechl6, and Manuel Mayr1

1 King's British Heart Foundation Centre, King's College London, London, United Kingdom; 2 Paris-Cardiovascular Research Center, Inserm U970, Hôpital Européen Georges Pompidou, Université Paris-Descartes, Paris, France; 3 King's College Hospital, National Health Service (NHS) Foundation Trust, Blood Sciences Laboratory Services, London, United Kingdom; 4 Department of Haematological Medicine, King's College London, London, United Kingdom; 5 Molecular Cardiology, Department of Medicine III, University of Frankfurt, Frankfurt, Germany; 6 Department of Neurology, Medical University Innsbruck, Innsbruck, Austria; 7 Center for Anatomy and Cell Biology, Medical University Vienna, Vienna, Austria; and 8 Department of Vascular Biology and Thrombosis Research, Centre for Bio-Molecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria

The concept of endothelial progenitor cells (EPCs) has attracted considerable interest in cardiovascular research, but despite a decade of research there are still no specific markers for EPCs and results from clinical trials remain controversial. Using liquid chromatography–tandem mass spectrometry, we analyzed the protein composition of microparticles (MPs) originating from the cell surface of EPC cultures. Our data revealed that the conventional methods for isolating mononuclear cells lead to a contamination with platelet proteins. Notably, platelets readily disintegrate into platelet MPs. These platelet MPs are taken up by the mononuclear cell population, which acquires "endothelial" characteristics (CD31, von Willebrand factor [VWF], lectin-binding), and angiogenic properties. In a large population-based study (n = 526), platelets emerged as a positive predictor for the number of colony-forming units and early outgrowth EPCs. Our study provides the first evidence that the cell type consistent with current definitions of an EPC phenotype may arise from an uptake of platelet MPs by mononuclear cells resulting in a gross misinterpretation of their cellular progeny. These findings demonstrate the advantage of using an unbiased proteomic approach to assess cellular phenotypes and advise caution in attributing the benefits in clinical trials using unselected bone marrow mononuclear cells (BMCs) to stem cell-mediated repair.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Platelet MPs obscure some EPC definitions
Mervin C. Yoder
Blood 2009 114: 495-496. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
M. C. Yoder
Platelet MPs obscure some EPC definitions
Blood, July 16, 2009; 114(3): 495 - 496.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020